Consideration of a cyclical delivery of semaglutide, and other AOMs, could be considered, where semaglutide is administered until a pre-determined body weight is achieved, at which point an interval period is commenced until a pre-determined percentage of weight is regained, before restarting treatment
Nausea Nausea is the most common GLP-1 side effect
Peptide therapy helps rewind time for a more vibrant appearance
[DOI] [PubMed] [Google Scholar] 17.Gerstein HC, Sattar N, Rosenstock J, et al
Tolerance to these adverse events can develop, but patients should contact their provider if intolerable
Our team members can fill in the gaps by analyzing your habits and making suggestions as to how you can build better ones